Pharmaceutical and healthcare companies operating in the US are strictly regulated by the Food and Drug Administration or the FDA. The FDA oversees the processes related to pharmaceutical drugs, biopharmaceuticals, healthcare, and more. They put a massive emphasis on the safety of the products, which makes pharmaceutical labeling a crucial element of such products.
Making an FDA-compliant pharmaceutical label is a tricky and meticulous process and a minor mistake can result in grave consequences. Not only are such mistakes a public health risk, but over 22% of detentions in the US take place because of labeling mistakes.
The FDA has a strict code when it comes to medicine labeling and all manufacturers, big or small, must adhere to these rules to get their product FDA approved. All human prescription drugs and biological products should follow the guidelines available in 21 CFR 201.56(d) and 201.57. The guidance also includes how manufacturers should format the labels, what information to highlight, and so on.
According to the FDA, a large section of products are classified as pharmaceutical products. Even a simple over-the-counter anti-dandruff treatment or a skincare product needs to adhere to the strict code of the FDA. The FDA regulates these products too because they affect the structure and function of the human body.
This list makes it quite clear that not all drugs are products that are sold in pharmacies. Toiletries or hand sanitizers are also products that the FDA will regulate. All these products require FDA-approved labeling.
In June 2006, the FDA made changes to the pharmaceutical labeling requirements for drugs and biological products (source). The goal of this initiative was to reduce the risks in medical product use. The new labeling scheme proposes what information the label will contain and how it will be organized. Here are some of the suggested changes:
For example, if a drug causes an adverse effect by interacting with a new drug introduced in the market, the manufacturer will have to update the pharmaceutical labeling. They have to mention this update in the Recent Major Changes section. Furthermore, other sections that have been introduced include patient counseling information and drug interactions.
The FDA states all the labeling requirements in the Title 21 of the Code of Federal Regulations, Part 201. The FDA is extremely strict with these rules and can misbrand drugs if manufacturers do not abide by these rules. The regulations for prescription drugs and over-the-counter drugs also differ.
Prescription drugs have information on the primary labeling as well as in the packaging insert. The following are the requirements for prescription drugs.
The packaging insert contains the FPI for the drug. The information in this part of the pharmaceutical labeling includes:
Other than these, the medicine labeling should also contain a clinical study summary, the storage, and handling information, and patient counseling information.
Over-the-counter or OTC drugs generally do not require a prescription. They mostly do not have packaging inserts. Their labels are usually big enough to enlist all the necessary material. The principal display panel of OTC drugs should have a statement of identity, brand name, company logo, net quantity, and dosage details.
The medicine labeling contains the "Drug Facts'' section. This area has the particulars regarding the active ingredient, the purpose of the drug, such as pain relief or fever reducer. It also states the specific uses and potential side effects. This panel also contains details on when to contact the doctor.
Other warnings that the manufacturer must print includes pregnancy and breastfeeding warning if it is only for external use and allergen information.
Pay attention to The guidelines, they also include how to make the text on the drug label readable. Since most prescription drugs have their information in the packaging inserts, their font sizes are small. The FDA has certain typefaces and text formatting rules listed to make the small text legible.
Counterfeiting is a massive problem in the pharma industry. In the United States, counterfeit steroids have killed 18 and affected about 100 individuals in 2012. In another instance in the same year, a cancer drug imported in the US had no active ingredients.
Recently, counterfeiters have exploited the demand for the COVID-19 vaccine too. Pfizer has identified fake vials of the COVID-19 vaccine that it has co-developed with BioNTech SE. Globally, the black market for the COVID-19 vaccine grew 400% on the dark web.
For counterfeiters, the US is a lucrative market as 40% of the annual prescription drug sales are made in the US. Therefore, protection and traceability are crucial for pharmaceutical products. Barcodes are essential when it comes to adding protective features to the packaging.
Here are some ways in which barcodes enhance functionality.
The FDA has a National Drug Code (NDC) number and barcode for every drug. Manufacturers, repackers, and labelers use this code to prove that the medicine satisfies FDA regulations. The NDC is a 10-digit code with three segments: a labeler code, a product code, and a packaging code.
Barcodes make it easier to check for lot numbers, expiration dates, and other data digitally. This can protect patients by preventing adverse events.
Barcodes improve the traceability of products. They help to check if drugs are contaminated or adulterated in any way. The barcodes also allow the FDA to recall products and stop all future productions.
The FDA does not regulate label materials for pharmaceutical products. Manufacturers commonly use multi-layer labels since they need to fit a lot of text in a small area. Ideally, labels that can stand chemical exposure, UV light, and moisture are suitable for such tasks. Laminated sheet labels and freezer stickers are also widely accepted.
The coronavirus pandemic has put a strain on the global economy. Businesses, small and large, are struggling from the immense fallout.
While big pharma companies are racing to make the vaccine available to everyone, a lot of small pharmaceutical companies grew in the US, Canada, and other regions too, to keep up with the increased medical requirements.
Pharmaceutical industries across the world have accelerated their manufacturing processes. Companies are now increasingly relying on digital tools to navigate through this global crisis. Projects like labeling design and approval now heavily rely on software platforms that allow stakeholders to collaborate and make the product available to the market.
The pandemic has increased the need for clinical trials. Labeling for clinical trials has different regulations and requirements. Manufacturers are adopting automated labeling software for clinical trials to make it easier to administer and track new and experimental drugs.
The FDA has a strict set of rules when it comes to drug labeling. Manufacturers, both big and small, must abide by these rules for the sake of public safety. Pharmaceutical labeling is also different for different categories of drugs. This guide provides a quick check for medicine labels, and what manufacturers should do to improve their thoroughness.